| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.800 | None | 0.952 | 6 | 1 | 2004 | 2019 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.700 | None | 0.961 | 16 | 10 | 2002 | 2020 | ||||||||
|
integrin subunit alpha M | 0.443 | 0.808 | 3.3E-11 |
|
disease | 0.700 | None | 1.000 | 9 | 6 | 2008 | 2019 | ||||||||
|
TNFAIP3 interacting protein 1 | 0.564 | 0.769 | 0.48 |
|
disease | 0.700 | None | 0.926 | 8 | 5 | 2009 | 2019 | ||||||||
|
TNF alpha induced protein 3 | 0.481 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.929 | 7 | 4 | 2008 | 2019 | ||||||||
|
interferon regulatory factor 5 | 0.489 | 0.731 | 9.0E-03 |
|
disease | 0.700 | None | 0.949 | 5 | 5 | 2005 | 2020 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
disease | 0.700 | None | 0.976 | 4 | 3 | 2008 | 2020 | ||||||||
|
B cell scaffold protein with ankyrin repeats 1 | 0.653 | 0.538 | 4.8E-12 |
|
disease | 0.700 | None | 0.955 | 3 | 5 | 2008 | 2019 | ||||||||
|
ETS proto-oncogene 1, transcription factor | 0.444 | 0.731 | 0.78 |
|
disease | 0.700 | None | 0.957 | 2 | 1 | 2000 | 2019 | ||||||||
|
interferon induced with helicase C domain 1 | 0.471 | 0.808 | 7.0E-44 |
|
disease | 0.700 | None | 1.000 | 2 | 1 | 2006 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.700 | None | 0.945 | 2 | 1 | 1994 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.700 | None | 0.882 | 2 | 2 | 1990 | 2019 | ||||||||
|
PX domain containing serine/threonine kinase like | 0.821 | 0.231 | 1.1E-02 |
|
disease | 0.670 | None | 0.875 | 2 | 3 | 2008 | 2015 | ||||||||
|
JAZF zinc finger 1 | 0.582 | 0.654 | 0.90 |
|
disease | 0.630 | None | 0.800 | 4 | 5 | 2009 | 2017 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.500 | None | 0.931 | 4 | 2 | 1991 | 2016 | ||||||||
|
Fc fragment of IgG receptor IIa | 0.480 | 0.769 | 2.0E-06 |
|
disease | 0.500 | None | 0.906 | 3 | 3 | 1995 | 2019 | ||||||||
|
interleukin 1 receptor associated kinase 1 | 0.506 | 0.808 | 0.99 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2007 | 2019 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2008 | 2018 | ||||||||
|
ubiquitin conjugating enzyme E2 L3 | 0.644 | 0.615 | 0.84 |
|
disease | 0.490 | None | 0.941 | 5 | 4 | 2008 | 2020 | ||||||||
|
PHD and ring finger domains 1 | 0.743 | 0.346 | 5.7E-02 |
|
disease | 0.470 | None | 0.875 | 2 | 1 | 2008 | 2012 | ||||||||
|
deoxyribonuclease 1 like 3 | 0.575 | 0.769 | 3.0E-05 |
|
disease | 0.470 | None | 1.000 | 1 | 1 | 2011 | 2020 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.450 | strong | 1.000 | 1 | 1 | 1976 | 2015 | ||||||||
|
solute carrier family 15 member 4 | 0.805 | 0.269 | 1.9E-06 |
|
disease | 0.440 | None | 1.000 | 4 | 4 | 2009 | 2017 | ||||||||
|
UHRF1 binding protein 1 | 0.769 | 0.269 | 4.5E-13 |
|
disease | 0.430 | None | 0.857 | 5 | 5 | 2009 | 2019 | ||||||||
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
disease | 0.410 | None | 1.000 | 4 | 5 | 2009 | 2017 |